文献速递糖尿病肥胖与代谢综合征

血浆脂质代谢物、临床血糖预测指标与 incident 2型糖尿病

Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2025-01-01

在FINRISK 2002队列(n=7,564)中开展非靶向血浆代谢物谱分析,随访14年,发现二酰甘油(DAG)与2型糖尿病风险升高相关(HR 1.22;95%CI 1.14-1.30),磷脂酰胆碱(PC)与风险降低相关(HR 0.78;95%CI 0.71-0.85)。DAG的关联独立于空腹血糖、HbA1c和空腹胰岛素,但不独立于2小时负荷后血糖;PC的关联独立于上述所有指标。在ARIC研究中验证,未观察到与种族的显著交互作用。

要点

  • 空腹DAG与2型糖尿病风险升高相关(HR 1.22;95%CI 1.14-1.30),独立于FPG、HbA1c和空腹胰岛素,但不独立于2hPG。
  • PC与2型糖尿病风险降低相关(HR 0.78;95%CI 0.71-0.85),独立于FPG、2hPG、HbA1c和空腹胰岛素。
  • DAG和PC与2型糖尿病的关联方向和强度在欧洲裔和非洲裔美国人中相似,未观察到与种族的显著交互作用。

核心结论

  • 空腹DAG可能捕获与2hPG相似的2型糖尿病风险信息;PC可能捕获不同于常规生物标志物所代表的2型糖尿病病因学方面。
  • DAG和PC与2型糖尿病关联的效应方向和强度在欧洲裔和非洲裔美国人中相似。

研究设计与样本

  • 在FINRISK 2002队列(n=7,564)参与者中开展非靶向血浆代谢物谱分析,采用Cox回归模型识别与14年随访期间 incident 2型糖尿病相关的代谢物。
  • 使用高斯图模型将代谢物聚类为通路,对富集2型糖尿病生物标志物的聚类进一步检查其与空腹血糖(FPG)、2小时负荷后血糖(2hPG)、HbA1c或空腹胰岛素的共变关系。
  • 在Atherosclerosis Risk in Communities(ARIC)研究中开展验证分析和与种族的交互作用检验。

主要发现

  • 代表二酰甘油(DAG)和磷脂酰胆碱(PC)的两个代谢物聚类包含最多的与 incident 2型糖尿病相关的代谢物关联。
  • DAG与2型糖尿病发病率升高相关(HR 1.22;95%CI 1.14-1.30),独立于FPG、HbA1c和空腹胰岛素,但不独立于2hPG。
  • PC与2型糖尿病风险呈负相关(HR 0.78;95%CI 0.71-0.85),独立于FPG、2hPG、HbA1c和空腹胰岛素。
  • 未观察到DAG或PC与种族之间的显著交互作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Plasma metabolite profiling has uncovered several nonglycemic markers of incident type 2 diabetes (T2D). We investigated whether such biomarkers provide information about specific aspects of T2D etiology, such as impaired fasting glucose and impaired glucose tolerance, and whether their association with T2D risk varies by race. RESEARCH DESIGN AND METHODS: Untargeted plasma metabolite profiling was performed of participants in the FINRISK 2002 cohort (n = 7,564). Cox regression modeling was conducted to identify metabolites associated with incident T2D during 14 years of follow-up. Metabolites were clustered into pathways using Gaussian graphical modeling. Clusters enriched for T2D biomarkers were further examined for covariation with fasting plasma glucose (FPG), 2-h postchallenge plasma glucose (2hPG), HbA1c, or fasting insulin. Validation analyses and tests of interaction with race were performed in the Atherosclerosis Risk in Communities (ARIC) study. RESULTS: Two clusters of metabolites, representing diacylglycerols (DAGs) and phosphatidylcholines (PCs), contained the largest number of metabolite associations with incident T2D. DAGs associated with increased T2D incidence (hazard ratio [HR] 1.22; 95% CI 1.14-1.30) independent of FPG, HbA1c, and fasting insulin, but not 2hPG. PCs were inversely associated with T2D risk (HR 0.78; 95% CI 0.71-0.85) independent of FPG, 2hPG, HbA1c, and fasting insulin. No significant interaction between DAGs or PCs and race was observed. CONCLUSIONS: Fasting DAGs may capture information regarding T2D risk similar to that represented by 2hPG; PCs may capture aspects of T2D etiology that differ from those represented by conventional biomarkers. The direction of effect and strength of DAG and PC associations with incident T2D are similar across European and African Americans.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Begzati A, Godinez-Macias KP, Long T, et al. Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 Diabetes. Diabetes Care. 2025. PMID: 39761415. doi:10.2337/dc24-2266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。